Galapagos, a global biotechnology company, has appointed the founding CEO of its new subsidiary & announced the search for a ...

Repertoire Immune Medicines has entered into a collaboration and license agreement with Genentech to discover and develop innovative T cell-targeted immune medicines.

Singh will lead the discovery and clinical translation of peptide medicines, investing in new technologies, including data and computational science.

Antag Therapeutics, a biopharmaceutical company pioneering novel treatments for obesity, has appointed three new hires to support the Company’s next phase of growth following the recent initiation of ...

Join Mike O’Mara, COO of Cellipont Bioservices, and Marcia Blackmoore, VP of Customer Operations at L7 Informatics, for a ...